EUVIMEDEUVIMED entdecken
Crossref

A MODEL OF THE OPTIMAL IMMUNOTHERAPY OF PSORIASIS BY INTRODUCING IL-10 AND IL-22 INHIBITORS

PRITI KUMAR ROY, AMIT KUMAR ROY, EVGENII N. KHAILOV, FAHAD AL BASIR, ELLINA V. GRIGORIEVA

Journal of Biological Systems · 2020-09 · 28 (03) · 609-639

DOI: 10.1142/s0218339020500084 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biological Systems, online erschienen am 03.09.2020. Verfasst von PRITI KUMAR ROY und 4 weiteren Autor:innen. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: Indo-Russian joint research, Russian Foundation for Basic Research, JU-RUSA 2.0 Doctoral Fellowship.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Psoriasis is a chronic skin disease in which the process of hyper-proliferation (excessive division) of skin cells starts. Externally, psoriasis appears as red papules, on the surface of which there are scales of white–gray color. There is substantial evidence that T-helper cells take vital accountability for creating the hyper-proliferation of keratinocytes (skin cells), which causes itching of skin patches. In this paper, we propose a mathematical model describing the concentrations of T-helper and keratinocyte cell populations to predict cellular behaviors for psoriasis regulation under normal or anomalous immune circumstances. Local and global asymptotic stabilities of the model equilibria are investigated. Additionally, by introducing two scalar bounded controls into the model, the effect of combined immunotherapy using IL-10 and IL-22 inhibitors is analyzed. The optimal control problem of minimizing the cost of immune therapy and simultaneous optimizing the effect of this therapy on T-helper cells and keratinocytes proliferation is formulated and solved by applying the Pontryagin maximum principle. Within the restrictions of the proposed model, the obtained analytical and numerical outcomes suggest that the optimal strategy of injecting IL-10 and IL-22 inhibitors can be effective for psoriasis treatment.

Förderung

  • Indo-Russian joint research
  • Russian Foundation for Basic Research
  • JU-RUSA 2.0 Doctoral Fellowship

Zitieren

APA

ROY, P. K., ROY, A. K., KHAILOV, E. N., BASIR, F. A., & GRIGORIEVA, E. V. (2020). A MODEL OF THE OPTIMAL IMMUNOTHERAPY OF PSORIASIS BY INTRODUCING IL-10 AND IL-22 INHIBITORS. Journal of Biological Systems, 28(03), 609-639. https://doi.org/10.1142/s0218339020500084

Vancouver

ROY PK, ROY AK, KHAILOV EN, BASIR FA, GRIGORIEVA EV. A MODEL OF THE OPTIMAL IMMUNOTHERAPY OF PSORIASIS BY INTRODUCING IL-10 AND IL-22 INHIBITORS. Journal of Biological Systems. 2020;28(03):609-639. doi:10.1142/s0218339020500084

BibTeX
@article{ROY2020,
  author = {ROY, PRITI KUMAR and ROY, AMIT KUMAR and KHAILOV, EVGENII N. and BASIR, FAHAD AL and GRIGORIEVA, ELLINA V.},
  title = {A MODEL OF THE OPTIMAL IMMUNOTHERAPY OF PSORIASIS BY INTRODUCING IL-10 AND IL-22 INHIBITORS},
  journal = {Journal of Biological Systems},
  year = {2020},
  volume = {28},
  number = {03},
  pages = {609--639},
  doi = {10.1142/s0218339020500084}
}
Kostenlos starten →